0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Restraint in Use of High-Dose Fluorides To Treat Skeletal Disorders

Stephen J. Marx, MD
JAMA. 1978;240(15):1630-1631. doi:10.1001/jama.1978.03290150076034.
Text Size: A A A
Published online

There is presently no treatment generally recognized as completely satisfactory for involutional osteoporosis, a condition that may be found in more than 50% of women past age 60 years and in a lesser percent of men in the same age group.1 This disorder is associated with appreciable morbidity manifested most strikingly as femoral neck fractures or vertebral compression. Many drugs are currently being investigated in an effort to find a useful treatment. Among these drugs are several preparations of inorganic fluoride. Fluorides have also been used for treatment of otospongiosis (otosclerosis), a disorder with osteopenia of the bony capsule of the inner ear.2 We suspect that in certain settings high-dose fluoride is being used for treatment of involutional osteoporosis and other osteopenic disorders without systematic monitoring for either efficacy or complications of long-term treatment. The purpose of this editorial is to emphasize that fluoride treatment for skeletal disorders

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();